Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera

por Muik, Alexander, Wallisch, Ann-Kathrin, Sänger, Bianca, Swanson, Kena A., Mühl, Julia, Chen, Wei, Cai, Hui, Maurus, Daniel, Sarkar, Ritu, Türeci, Özlem, Dormitzer, Philip R., Şahin, Uğur
Publicado 2021

Neutralizing Activity of BNT162b2-Elicited Serum

por Liu, Yang, Liu, Jianying, Xia, Hongjie, Zhang, Xianwen, Fontes-Garfias, Camila R., Swanson, Kena A., Cai, Hui, Sarkar, Ritu, Chen, Wei, Cutler, Mark, Cooper, David, Weaver, Scott C., Muik, Alexander, Sahin, Ugur, Jansen, Kathrin U., Xie, Xuping, Dormitzer, Philip R., Shi, Pei-Yong
Publicado 2021

BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants

por Liu, Yang, Liu, Jianying, Xia, Hongjie, Zhang, Xianwen, Zou, Jing, Fontes-Garfias, Camila R., Weaver, Scott C., Swanson, Kena A., Cai, Hui, Sarkar, Ritu, Chen, Wei, Cutler, Mark, Cooper, David, Muik, Alexander, Sahin, Ugur, Jansen, Kathrin U., Xie, Xuping, Dormitzer, Philip R., Shi, Pei-Yong
Publicado 2021